|
⚲
|
| Keyboard |
| BeiGene Ltd | |
|---|---|
| Ticker | ONC |
| CIK # | 0001651308 |
| CUSIP | 07725L102 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | c/o Mourant Ozannes Corporate Services 94 Solaris Avenue, Camana Bay, Grand Cayman, KY1-1108 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001651308] | 10-K | |
| [0001651308] | 10-Q | |
| [0001651308] | 3 | |
| [0001651308] | 4 | |
| [0001651308] | 5 | |
| [0001651308] | 8-K | |
| [0001651308] | SC 13D | |
| [0001651308] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Invesco Ltd | BeiGene Ltd | [2022-02-11] | 5.6 |
| BeiGene Ltd | Leap Therapeutics Inc | [2020-03-23] | 23.7 |
| Capital International Investors | BeiGene Ltd | [2020-01-10] | 10.0 |
| Amgen Inc | BeiGene Ltd | [2020-01-08] | 20.5 |
| BeiGene Ltd | BeiGene Ltd | [2019-02-12] | 0.4 |
| Wellington Management Group LLP | BeiGene Ltd | [2018-02-08] | 8.39 |
| Celgene Corp /DE/ | BeiGene Ltd | [2017-09-01] | 5.6 |
| Oyler John | BeiGene Ltd | [2017-02-13] | 15.8 |
| FMR LLC | BeiGene Ltd | [2017-01-10] | 0.0 |
| Hillhouse Capital Management Ltd | BeiGene Ltd | [2016-02-18] | 0.29 |
| Merck & Co Inc | BeiGene Ltd | [2016-02-12] | 7.4 |
| Baker Bros Advisors LP | BeiGene Ltd | [2016-02-09] | 24.6 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lee Chan Henry
American Depositary Shares
|
2026-03-11 | Option exercise | 110 | $194.47 | 21,392 |
|
Lee Chan Henry
Share Option (Right to Buy) · derivative
|
2026-03-11 | Option exercise | 1,430 | $0.00 | |
|
Lee Chan Henry
Share Option (Right to Buy) · derivative
|
2026-03-11 | Option exercise | 1,274 | $0.00 | |
|
Lee Chan Henry
American Depositary Shares
|
2026-03-11 | Option exercise | 133 | $213.32 | 28,372 |
|
Lee Chan Henry
Share Option (Right to Buy) · derivative
|
2026-03-11 | Option exercise | 1,729 | $0.00 | |
|
Lee Chan Henry
American Depositary Shares
|
2026-03-11 | Sell | 341 | $300.00 | 102,300 |
|
Lee Chan Henry
American Depositary Shares
|
2026-03-11 | Option exercise | 98 | $159.03 | 15,585 |
|
Wu Xiaobin
Ordinary Shares
|
2026-03-06 | Grant | 78,624 | $0.00 | |
|
Wang Lai
Ordinary Shares
|
2026-03-06 | Grant | 112,606 | $0.00 | |
|
Wang Lai
Ordinary Shares
|
2026-03-06 | Grant | 55,029 | $0.00 | |
|
Rosenberg Aaron
Ordinary Shares
|
2026-03-06 | Grant | 79,014 | $0.00 | |
|
Lee Chan Henry
Ordinary Shares
|
2026-03-06 | Grant | 29,874 | $0.00 | |
|
Oyler John
Ordinary Shares
|
2026-03-06 | Grant | 326,976 | $0.00 | |
|
Oyler John
Ordinary Shares
|
2026-03-06 | Grant | 117,936 | $0.00 | |
|
Rosenberg Aaron
Ordinary Shares
|
2026-03-06 | Grant | 40,573 | $0.00 | |
|
Lee Chan Henry
Ordinary Shares
|
2026-03-06 | Grant | 65,390 | $0.00 | |
|
Wu Xiaobin
Ordinary Shares
|
2026-03-06 | Grant | 168,922 | $0.00 | |
|
Lee Chan Henry
Share Option (Right to Buy) · derivative
|
2026-02-04 | Option exercise | 6,448 | $0.00 | |
|
Lee Chan Henry
American Depositary Shares
|
2026-02-04 | Option exercise | 502 | $194.47 | 97,624 |
|
Lee Chan Henry
American Depositary Shares
|
2026-02-04 | Option exercise | 662 | $213.32 | 141,218 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 282 | 34,408,441 |
| 2025-12-31 | 289 | 32,624,418 |
| 2025-09-30 | 269 | 31,654,091 |
| 2025-06-30 | 246 | 33,569,672 |
| 2025-03-31 | 271 | 39,849,940 |
| 2024-12-31 | 231 | 40,846,868 |
| 2024-09-30 | 231 | 44,101,049 |
| 2024-06-30 | 199 | 44,541,608 |
| 2024-03-31 | 205 | 44,609,425 |
| 2023-12-31 | 206 | 43,193,392 |
| 2023-09-30 | 199 | 45,009,846 |
| 2023-06-30 | 209 | 45,443,026 |